COVID Vaccines, what’s new: an update on the latest clinical trials that are underway with the currently administered vaccines The global pandemic posed a challenge for […]

This week we saw two major deals in the ADC landscape of oncology:   Gilead acquired Immunomedic’s Trop2-directed Trodelvy in a $21B deal, giving the company […]